Central and peripheral molecular targets for antiobesity pharmacotherapy. Clinical pharmacology and therapeutics vol
Kalra, S., Sahay, R., & Gupta, Y
T.ChuaB
The hepatic extraction of insulin, ISR,and glucagon secretion on both study days for participants without diabetes ( n = 12) are shown in A , C , and E , respectively
One day early falls comfortably inside it
Chromium supplements may improve blood sugar control and insulin resistance in people with type 2 diabetes and other conditions, but the evidence is not consistent across all studies, and it may be more effective in those with chromium deficiency